We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00308178
Recruitment Status : Completed
First Posted : March 29, 2006
Last Update Posted : February 18, 2013
Celgene Corporation
Beth Israel Deaconess Medical Center
Massachusetts General Hospital
Information provided by (Responsible Party):
Harold J. Burstein, MD, PhD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2006
  Study Completion Date : June 2008